Arvind Kumar Morya
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Arvind Kumar Morya has a total of 127 co-authors. Here are the top co-authors by number of shared publications:
Prateek Nishant
Department of Ophthalmology-Refractive Surgery, Uvea and Neuro-Ophthalmology, Akhand Jyoti Eye Hospital, Saran 841219, Bihar, India
20 shared publicationsSony Sinha
Department of Ophthalmology-Vitreo-Retina, Neuro-Ophthalmology and Oculoplasty, All India Institute of Medical Sciences, Patna 801507, Bihar, India
18 shared publicationsBharat Gurnani
Department of Ophthalmology, Gomabai Netralaya and Research Centre, Neemuch 458441, Madhya Pradesh, India
11 shared publicationsAntarvedi Tejaswini
All India Institute of Medical Sciences, Bibinagar, Telangana, India
10 shared publicationsKirandeep Kaur
Cataract, Pediatric Ophthalmology and Strabismus, Gomabai Netralaya and Research Centre, Neemuch 458441, Madhya Pradesh, India
10 shared publicationsArshi Singh
9 shared publications
Latest Publications
- Open Access
- 20 September 2026
- Published by Baishideng Publishing Group Inc. in World Journal of Methodology
- Vol. 16 (3)
Anti-obesity medications impacting the eye: An emerging concern - a narrative review
Obesity has reached epidemic proportions globally, with projections indicating that by 2050, nearly 3.8 billion adults will be overweight or obese. Despite the critical need for effective interventions, current obesity treatments ranging from lifestyle changes to bariatric surgery are often limited in efficacy or suitability. Pharmacotherapy is increasingly utilized for individuals with significant obesity or related comorbidities. However, some anti-obesity medications have been linked to ocular complications such as non-arteritic anterior ischemic optic neuropathy and diabetic retinopathy progression. This review analyzes currently approved anti-obesity medications, emphasizing their potential ocular adverse effects and the underlying mechanisms by which these occur. A comprehensive literature search identified the historical evolution, classification, and spectrum of ocular effects associated with these agents. The findings underscore the importance of evaluating both the risks and benefits of anti-obesity pharmacotherapy and highlight the need for vigilant clinical assessment of ocular health in patients undergoing such treatments.
- 20 September 2026
- Published by Baishideng Publishing Group Inc. in World Journal of Methodology
- Vol. 16 (3)
Open AccessAnti-obesity medications impacting the eye: An emerging concern - a narrative review
Obesity has reached epidemic proportions globally, with projections indicating that by 2050, nearly 3.8 billion adults will be overweight or obese. Despite the critical need for effective interventions, current obesity treatments ranging from lifestyle changes to bariatric surgery are often limited in efficacy or suitability. Pharmacotherapy is increasingly utilized for individuals with significant obesity or related comorbidities. However, some anti-obesity medications have been linked to ocular complications such as non-arteritic anterior ischemic optic neuropathy and diabetic retinopathy progression. This review analyzes currently approved anti-obesity medications, emphasizing their potential ocular adverse effects and the underlying mechanisms by which these occur. A comprehensive literature search identified the historical evolution, classification, and spectrum of ocular effects associated with these agents. The findings underscore the importance of evaluating both the risks and benefits of anti-obesity pharmacotherapy and highlight the need for vigilant clinical assessment of ocular health in patients undergoing such treatments.
- 4 August 2026
- Published by Taylor & Francis in Neuro-Ophthalmology
- p. 1-9
Implantable and Device-Based Nanomedicine Platforms in Glaucoma and Optic Neuropathies: A Narrative Review Bridging Pharmacology and Biomedical Engineering
Neuro-ophthalmology science assesses and manages the treatment for optic neuropathies and other disorders of the visual pathways.1 Globally, major diseases, such as glaucoma, optic neuropathies (is...
- 4 August 2026
- Published by Taylor & Francis in Neuro-Ophthalmology
- p. 1-9
Implantable and Device-Based Nanomedicine Platforms in Glaucoma and Optic Neuropathies: A Narrative Review Bridging Pharmacology and Biomedical Engineering
Neuro-ophthalmology science assesses and manages the treatment for optic neuropathies and other disorders of the visual pathways.1 Globally, major diseases, such as glaucoma, optic neuropathies (is...
- 1 June 2026
- Published by TARUS Media in Mædica
- Vol. 21 (2) , 414-423
A Randomized Clinical Study to Compare the Effectiveness of the Orthoptek Magnocellular Stimulator, Occlu-tab and Phakic Intraocular Lens in Refractive Amblyopia of Older Children and Young Adults.
The conventional management modality of refractive amblyopia is patching of the normal eye, which has high recurrence rates. Modern technological advancements have the potential to offer comprehensive visual rehabilitation and improvement in binocular single vision. To compare the clinical efficacy of three novel interventions - Phakic intraocular lens (IOL), Occlu-tab and Orthoptek Magnocellular Stimulator - in managing refractive amblyopia in adolescents and young adults. Young adults with refractive amblyopia who did not respond to occlusion therapy were randomized into three groups: Occlu-tab, Orthoptek and Phakic IOL. Pre- and post-treatment best-corrected visual acuity (BCVA), contrast sensitivity and stereoacuity were assessed. All three modalities produced significant within-group improvements in BCVA, contrast sensitivity and stereoacuity (p < 0.001). Best-corrected visual acuity improved comparably across the three groups, including Orthoptek (mean gain 0.44), Occlu-tab (0.34) and Phakic IOL (0.29 logMAR). There was no statistically significant difference between groups (p = 0.136). Contrast sensitivity gains were higher for Occlu-tab (+0.78) and Orthoptek (+0.78) than for Phakic IOL (+0.59), with a significant between-group difference (p = 0.003). Stereoacuity has markedly improved with Occlu-tab (715.62 sec arc) and Orthoptek (713.54 sec arc) versus less improvement with a Phakic IOL (312.50 sec arc), with the between-group difference being highly significant (p < 0.001). In terms of final binocular functional success rates, Orthoptek and Occlu-tab therapies were superior as compared to Phakic IOLs. A combination of amblyopia therapies should be the approach in the near future.
- 1 June 2026
- Published by TARUS Media in Mædica
- Vol. 21 (2) , 414-423
A Randomized Clinical Study to Compare the Effectiveness of the Orthoptek Magnocellular Stimulator, Occlu-tab and Phakic Intraocular Lens in Refractive Amblyopia of Older Children and Young Adults.
The conventional management modality of refractive amblyopia is patching of the normal eye, which has high recurrence rates. Modern technological advancements have the potential to offer comprehensive visual rehabilitation and improvement in binocular single vision. To compare the clinical efficacy of three novel interventions - Phakic intraocular lens (IOL), Occlu-tab and Orthoptek Magnocellular Stimulator - in managing refractive amblyopia in adolescents and young adults. Young adults with refractive amblyopia who did not respond to occlusion therapy were randomized into three groups: Occlu-tab, Orthoptek and Phakic IOL. Pre- and post-treatment best-corrected visual acuity (BCVA), contrast sensitivity and stereoacuity were assessed. All three modalities produced significant within-group improvements in BCVA, contrast sensitivity and stereoacuity (p < 0.001). Best-corrected visual acuity improved comparably across the three groups, including Orthoptek (mean gain 0.44), Occlu-tab (0.34) and Phakic IOL (0.29 logMAR). There was no statistically significant difference between groups (p = 0.136). Contrast sensitivity gains were higher for Occlu-tab (+0.78) and Orthoptek (+0.78) than for Phakic IOL (+0.59), with a significant between-group difference (p = 0.003). Stereoacuity has markedly improved with Occlu-tab (715.62 sec arc) and Orthoptek (713.54 sec arc) versus less improvement with a Phakic IOL (312.50 sec arc), with the between-group difference being highly significant (p < 0.001). In terms of final binocular functional success rates, Orthoptek and Occlu-tab therapies were superior as compared to Phakic IOLs. A combination of amblyopia therapies should be the approach in the near future.
- Open Access
- 20 March 2026
- Published by Baishideng Publishing Group Inc. in World Journal of Methodology
- Vol. 16 (1) , 110410
Role of lifestyle modifications in glaucoma: A systematic review
BACKGROUND Glaucoma is a group of eye diseases that lead to irreversible damage to the optic nerve and gradual vision loss. Although it can occur at any age, it is most commonly seen in people over 40. Globally, around 60.5 million people are currently affected, and this number is expected to rise to over 110 million by 2040. Often called the “silent thief of sight”, glaucoma typically progresses without noticeable symptoms until significant vision has already been lost, making it a major cause of visual disability worldwide. Despite advancements in research, lowering intraocular pressure (IOP) remains the only proven way to slow or halt disease progression. AIM To explore the potential role of lifestyle modifications in the prevention and management of glaucoma, particularly as complementary strategies alongside traditional IOP-lowering treatments. METHODS An extensive review of existing literature was carried out to examine the effects of various lifestyle factors—including diet, physical activity, yoga practices, sleep posture, and the use of nutritional supplements-on the development and progression of glaucoma. RESULTS Several studies suggest that lifestyle changes may have a positive impact on glaucoma outcomes. Regular physical exercise, balanced nutrition, certain yoga postures, and proper sleep positioning have been associated with benefits for eye health. Additionally, some supplements may support the optic nerve and contribute to slowing disease progression. These approaches, which are already recognized in the management of other chronic conditions like diabetes and hypertension, show promise in glaucoma care as well. CONCLUSION While lowering IOP remains the cornerstone of glaucoma treatment, there is growing interest in the role of lifestyle choices in influencing disease progression. Adopting healthier habits may serve as a valuable addition to existing treatment plans. More clinical research is needed to better understand these connections and to guide practical recommendations for patients and clinicians alike.
- 20 March 2026
- Published by Baishideng Publishing Group Inc. in World Journal of Methodology
- Vol. 16 (1) , 110410
Open AccessRole of lifestyle modifications in glaucoma: A systematic review
BACKGROUND Glaucoma is a group of eye diseases that lead to irreversible damage to the optic nerve and gradual vision loss. Although it can occur at any age, it is most commonly seen in people over 40. Globally, around 60.5 million people are currently affected, and this number is expected to rise to over 110 million by 2040. Often called the “silent thief of sight”, glaucoma typically progresses without noticeable symptoms until significant vision has already been lost, making it a major cause of visual disability worldwide. Despite advancements in research, lowering intraocular pressure (IOP) remains the only proven way to slow or halt disease progression. AIM To explore the potential role of lifestyle modifications in the prevention and management of glaucoma, particularly as complementary strategies alongside traditional IOP-lowering treatments. METHODS An extensive review of existing literature was carried out to examine the effects of various lifestyle factors—including diet, physical activity, yoga practices, sleep posture, and the use of nutritional supplements-on the development and progression of glaucoma. RESULTS Several studies suggest that lifestyle changes may have a positive impact on glaucoma outcomes. Regular physical exercise, balanced nutrition, certain yoga postures, and proper sleep positioning have been associated with benefits for eye health. Additionally, some supplements may support the optic nerve and contribute to slowing disease progression. These approaches, which are already recognized in the management of other chronic conditions like diabetes and hypertension, show promise in glaucoma care as well. CONCLUSION While lowering IOP remains the cornerstone of glaucoma treatment, there is growing interest in the role of lifestyle choices in influencing disease progression. Adopting healthier habits may serve as a valuable addition to existing treatment plans. More clinical research is needed to better understand these connections and to guide practical recommendations for patients and clinicians alike.
- Open Access
- 26 February 2026
- Published by Baishideng Publishing Group Inc. in World Journal of Clinical Cases
- Vol. 14 (6)
Tubercular chorioretinitis mimicking sarcoidosis in a patient with celiac disease and erythema nodosum: A case report
BACKGROUND Tuberculosis remains an important cause of uveitis in tuberculosis-endemic regions and can closely resemble other granulomatous disorders, such as sarcoidosis, especially in the presence of erythema nodosum. The diagnosis is even more challenging in the presence of an underlying autoimmune condition such as celiac disease. CASE SUMMARY We report a case of a middle-aged female, a known case of celiac disease and recurrent severe anaemia presenting with progressive, recurring episodes of bilateral diminished vision, ocular pain, photophobia, and floaters over a period of 1.5 years. Ocular examination revealed bilateral vitritis with chorioretinal lesions consistent with posterior uveitis, more severe in the left eye. Initially, the presence of erythema nodosum and systemic symptoms raised the possibility of sarcoidosis; however, an extensive systemic workup ruled it out. A positive QuantiFERON-TB Gold test, past history of treated cervical lymph node tuberculosis, relevant family history, and favourable clinical response to antitubercular therapy favoured the diagnosis of presumed tubercular chorioretinitis. The treatment included antitubercular therapy, systemic corticosteroids, and posterior subtenon triamcinolone injections which led to clinical improvement; however, there was a recurrence of the disease after completing treatment, which required initiation of systemic azathioprine. CONCLUSION This case highlights the need for a high index of suspicion for ocular tuberculosis in patients presenting with posterior uveitis and erythema nodosum. Detailed assessment and exclusion of close differentials are essential so that timely diagnosis and optimum management can be done, especially in endemic areas.
- 26 February 2026
- Published by Baishideng Publishing Group Inc. in World Journal of Clinical Cases
- Vol. 14 (6)
Open AccessTubercular chorioretinitis mimicking sarcoidosis in a patient with celiac disease and erythema nodosum: A case report
BACKGROUND Tuberculosis remains an important cause of uveitis in tuberculosis-endemic regions and can closely resemble other granulomatous disorders, such as sarcoidosis, especially in the presence of erythema nodosum. The diagnosis is even more challenging in the presence of an underlying autoimmune condition such as celiac disease. CASE SUMMARY We report a case of a middle-aged female, a known case of celiac disease and recurrent severe anaemia presenting with progressive, recurring episodes of bilateral diminished vision, ocular pain, photophobia, and floaters over a period of 1.5 years. Ocular examination revealed bilateral vitritis with chorioretinal lesions consistent with posterior uveitis, more severe in the left eye. Initially, the presence of erythema nodosum and systemic symptoms raised the possibility of sarcoidosis; however, an extensive systemic workup ruled it out. A positive QuantiFERON-TB Gold test, past history of treated cervical lymph node tuberculosis, relevant family history, and favourable clinical response to antitubercular therapy favoured the diagnosis of presumed tubercular chorioretinitis. The treatment included antitubercular therapy, systemic corticosteroids, and posterior subtenon triamcinolone injections which led to clinical improvement; however, there was a recurrence of the disease after completing treatment, which required initiation of systemic azathioprine. CONCLUSION This case highlights the need for a high index of suspicion for ocular tuberculosis in patients presenting with posterior uveitis and erythema nodosum. Detailed assessment and exclusion of close differentials are essential so that timely diagnosis and optimum management can be done, especially in endemic areas.
- Open Access
- 6 February 2026
- Published by Baishideng Publishing Group Inc. in World Journal of Clinical Cases
- Vol. 14 (4)
Safety and efficacy of keratorefractive surgery in diabetes mellitus: A clinical review
Keratorefractive surgery is typically performed to correct refractive errors, resulting in good postoperative outcomes. Certain conditions, such as autoimmune diseases, metabolic diseases like diabetes mellitus (DM), and the use of some drugs, may be absolutely or relatively contraindicated for refractive surgery. DM is a multisystemic disorder affecting various organs and can result in retinopathy, nephropathy, and neuropathy. Persistent hyperglycemia leads to various pathophysiological changes that can alter the biomechanical profile and the wound healing process of the cornea. Proper patient counselling, optimizing blood glucose levels, and frequent follow-up visits to monitor and manage potential complications, such as dry eye, non-healing epithelial defects, and neurotrophic keratitis, are essential for refractive surgeons. Laser-assisted in situ keratomileusis is preferred over photorefractive keratectomy due to its faster healing process. Cataract surgery in people with diabetes warrants various preoperative, intraoperative, and postoperative considerations for the best visual outcomes. This review focuses on the current evidence pertaining to various structural and functional corneal changes occurring in diabetics and their impact on keratorefractive procedures, thus providing a unified, clinically oriented framework to guide refractive surgeons in risk stratification, procedure selection, and postoperative management in patients with DM.
- 6 February 2026
- Published by Baishideng Publishing Group Inc. in World Journal of Clinical Cases
- Vol. 14 (4)
Open AccessSafety and efficacy of keratorefractive surgery in diabetes mellitus: A clinical review
Keratorefractive surgery is typically performed to correct refractive errors, resulting in good postoperative outcomes. Certain conditions, such as autoimmune diseases, metabolic diseases like diabetes mellitus (DM), and the use of some drugs, may be absolutely or relatively contraindicated for refractive surgery. DM is a multisystemic disorder affecting various organs and can result in retinopathy, nephropathy, and neuropathy. Persistent hyperglycemia leads to various pathophysiological changes that can alter the biomechanical profile and the wound healing process of the cornea. Proper patient counselling, optimizing blood glucose levels, and frequent follow-up visits to monitor and manage potential complications, such as dry eye, non-healing epithelial defects, and neurotrophic keratitis, are essential for refractive surgeons. Laser-assisted in situ keratomileusis is preferred over photorefractive keratectomy due to its faster healing process. Cataract surgery in people with diabetes warrants various preoperative, intraoperative, and postoperative considerations for the best visual outcomes. This review focuses on the current evidence pertaining to various structural and functional corneal changes occurring in diabetics and their impact on keratorefractive procedures, thus providing a unified, clinically oriented framework to guide refractive surgeons in risk stratification, procedure selection, and postoperative management in patients with DM.
- 5 February 2026
- Published by SAGE Publications in European Journal of Ophthalmology
- Vol. 36 (3) , 492-511
“Optimizing IOL centration in cataract surgery: Narrative review of techniques, challenges, and outcomes”
Intraocular lens (IOL) centration is pivotal in determining the visual quality and refractive success after cataract surgery, especially with premium IOLs such as multifocal, extended depth of focus (EDOF), and toric lenses. Despite the surgical and technological advancements, achieving perfect centration of the IOL remains a challenge, influenced by anatomical variations and intraoperative variables. Different preoperative variables, such as the patient's refractive status, the technique of axis marking, calculation of IOL power, IOL material and design, and measurement of visual angles, have a significant impact on the final visual outcome. Intraoperatively, following the correct surgical principles like creating a central capsulorhexis of adequate size, maintaining the zonular integrity, in-the-bag IOL placement on its planned axis, and various techniques to maintain this centration are important determinants of final optimal visual outcomes. This review intends to describe the current techniques employed for IOL centration, common challenges, and clinical outcomes. It also highlights the recent innovations that aim to improve the IOL centration accuracy and patient satisfaction.
- 5 February 2026
- Published by SAGE Publications in European Journal of Ophthalmology
- Vol. 36 (3) , 492-511
“Optimizing IOL centration in cataract surgery: Narrative review of techniques, challenges, and outcomes”
Intraocular lens (IOL) centration is pivotal in determining the visual quality and refractive success after cataract surgery, especially with premium IOLs such as multifocal, extended depth of focus (EDOF), and toric lenses. Despite the surgical and technological advancements, achieving perfect centration of the IOL remains a challenge, influenced by anatomical variations and intraoperative variables. Different preoperative variables, such as the patient's refractive status, the technique of axis marking, calculation of IOL power, IOL material and design, and measurement of visual angles, have a significant impact on the final visual outcome. Intraoperatively, following the correct surgical principles like creating a central capsulorhexis of adequate size, maintaining the zonular integrity, in-the-bag IOL placement on its planned axis, and various techniques to maintain this centration are important determinants of final optimal visual outcomes. This review intends to describe the current techniques employed for IOL centration, common challenges, and clinical outcomes. It also highlights the recent innovations that aim to improve the IOL centration accuracy and patient satisfaction.
- Open Access
- 26 January 2026
- Published by Baishideng Publishing Group Inc. in World Journal of Clinical Cases
- Vol. 14 (3)
Ocular health in outer space and beyond gravity: A minireview
Prolonged exposure to microgravity profoundly influences ocular physiology, giving rise to spaceflight-associated neuro-ocular syndrome (SANS), a significant concern for astronauts on long-duration missions. This review consolidates current evidence on ocular adaptations to spaceflight, encompassing pathophysiological mechanisms, diagnostic advances, related ocular conditions, and emerging countermeasures. Literature published between 2000 and 2025 was systematically examined across PubMed, Scopus, and Web of Science, integrating both peer-reviewed studies and technical reports from the National Aeronautics and Space Administration and the European Space Agency. Findings indicate that ocular changes consistent with SANS affect approximately one-third of astronauts, with higher prevalence during missions exceeding six months. Hallmark features include optic disc edema, posterior globe flattening, and mild hyperopic shifts, attributed to cephalad fluid shifts, altered cerebrospinal fluid dynamics, venous congestion, and impaired glymphatic flow. Besides SANS, microgravity predisposes astronauts to dry eye disease, immune-related infections, and radiation-induced cataracts. Recent advances in in-flight optical coherence tomography, optical coherence tomography angiography, and ultrasound have enhanced early detection, while countermeasures such as lower body negative pressure, artificial gravity, and artificial intelligence-driven ocular monitoring show promise. Understanding ocular adaptations to space not only mitigates mission risks but also enriches terrestrial knowledge of intracranial pressure regulation and neuro-ophthalmic health.
- 26 January 2026
- Published by Baishideng Publishing Group Inc. in World Journal of Clinical Cases
- Vol. 14 (3)
Open AccessOcular health in outer space and beyond gravity: A minireview
Prolonged exposure to microgravity profoundly influences ocular physiology, giving rise to spaceflight-associated neuro-ocular syndrome (SANS), a significant concern for astronauts on long-duration missions. This review consolidates current evidence on ocular adaptations to spaceflight, encompassing pathophysiological mechanisms, diagnostic advances, related ocular conditions, and emerging countermeasures. Literature published between 2000 and 2025 was systematically examined across PubMed, Scopus, and Web of Science, integrating both peer-reviewed studies and technical reports from the National Aeronautics and Space Administration and the European Space Agency. Findings indicate that ocular changes consistent with SANS affect approximately one-third of astronauts, with higher prevalence during missions exceeding six months. Hallmark features include optic disc edema, posterior globe flattening, and mild hyperopic shifts, attributed to cephalad fluid shifts, altered cerebrospinal fluid dynamics, venous congestion, and impaired glymphatic flow. Besides SANS, microgravity predisposes astronauts to dry eye disease, immune-related infections, and radiation-induced cataracts. Recent advances in in-flight optical coherence tomography, optical coherence tomography angiography, and ultrasound have enhanced early detection, while countermeasures such as lower body negative pressure, artificial gravity, and artificial intelligence-driven ocular monitoring show promise. Understanding ocular adaptations to space not only mitigates mission risks but also enriches terrestrial knowledge of intracranial pressure regulation and neuro-ophthalmic health.
- Open Access
- 19 January 2026
- Published by Baishideng Publishing Group Inc. in World Journal of Psychiatry
- Vol. 16 (1) , 111118
Psychiatric disorders linked to visual impairment: A review of mental health challenges and interventions across age groups
The intersection of visual impairment and mental health has profound effects on quality of life and warrants attention from healthcare providers, educators, and policymakers. With 20 million children under the age of 14 affected globally, older adults also experience significant psychological impact including depression, anxiety, and cognitive impairment. The implications of vision-related challenges extend far beyond mere sight. Depression and anxiety, exacerbated by social isolation and reduced physical activity, underscore the need for comprehensive interventions that address both medical and psychosocial dimensions. By recognizing the profound impact of ocular morbidities like strabismus, myopia, glaucoma, and age-related macular degeneration on mental health and investing in effective treatments and inclusive practices, society can pave the way for a healthier, more equitable future for affected individuals. There is evidence that myopic children experience a higher prevalence of depressive symptoms compared to their normal peers, and interventions like the correction of strabismus can enhance psychological outcome - demonstrating the value of an integrated management approach.
- 19 January 2026
- Published by Baishideng Publishing Group Inc. in World Journal of Psychiatry
- Vol. 16 (1) , 111118
Open AccessPsychiatric disorders linked to visual impairment: A review of mental health challenges and interventions across age groups
The intersection of visual impairment and mental health has profound effects on quality of life and warrants attention from healthcare providers, educators, and policymakers. With 20 million children under the age of 14 affected globally, older adults also experience significant psychological impact including depression, anxiety, and cognitive impairment. The implications of vision-related challenges extend far beyond mere sight. Depression and anxiety, exacerbated by social isolation and reduced physical activity, underscore the need for comprehensive interventions that address both medical and psychosocial dimensions. By recognizing the profound impact of ocular morbidities like strabismus, myopia, glaucoma, and age-related macular degeneration on mental health and investing in effective treatments and inclusive practices, society can pave the way for a healthier, more equitable future for affected individuals. There is evidence that myopic children experience a higher prevalence of depressive symptoms compared to their normal peers, and interventions like the correction of strabismus can enhance psychological outcome - demonstrating the value of an integrated management approach.
- Open Access
- 22 December 2025
- Published by Baishideng Publishing Group Inc. in World Journal of Gastrointestinal Pathophysiology
- Vol. 16 (4)
Role of gut microbiomes in different ocular pathologies: A systematic review
BACKGROUND The gut microbiome is integral to human health, with emerging research underscoring its potential impact on ocular health through the gut-eye axis. Various ocular disorders, such as dry eye syndrome, retinal vascular diseases, macular degeneration, and glaucoma, may be influenced by gut dysbiosis, which could significantly contribute to their development and progression. AIM To evaluate the influence of the gut microbiome on the pathogenesis and progression of various ocular diseases. METHODS An extensive search of the scientific literature was undertaken by adhering to Preferred Reporting Items for Systematic Reviews & Meta-Analyses standards, using PubMed (MEDLINE), Scopus, EMBASE, and the Cochrane Library as sources to locate studies addressing the relationship between the gut microbiome and human health. To capture all relevant publications, search terms were systematically applied across these major databases, without limiting the search by language or publication date. Inclusion criteria covered randomized controlled trials, non-randomized controlled trial, prospective studies, cross-sectional studies, and case-control studies. Out of the 3077 articles, 36 full texts were included in the review. RESULTS Ocular health appears to be shaped by the gut microbial community through mechanisms such as immune regulation, preservation of the blood–retinal barrier, and the generation of protective metabolites. Disturbances in this microbial balance can provoke measurable alterations in host immunity, providing a plausible immunopathogenic pathway that connects intestinal dysbiosis with eye disease. Both laboratory models and early human data suggest that targeted interventions, including prebiotics, probiotics, synbiotics, and faecal microbiota transfer, hold therapeutic potential. CONCLUSION The gut–eye relationship reflects a multifaceted interaction in which the intestinal microbiome contributes to ocular health through complex biological pathways. Integrating microbiome assessments into diagnostic methods can revolutionize disease management through early detection and targeted interventions. Further, randomised controlled clinical trials are necessary for ocular diseases to prove causal relationships.
- 22 December 2025
- Published by Baishideng Publishing Group Inc. in World Journal of Gastrointestinal Pathophysiology
- Vol. 16 (4)
Open AccessRole of gut microbiomes in different ocular pathologies: A systematic review
BACKGROUND The gut microbiome is integral to human health, with emerging research underscoring its potential impact on ocular health through the gut-eye axis. Various ocular disorders, such as dry eye syndrome, retinal vascular diseases, macular degeneration, and glaucoma, may be influenced by gut dysbiosis, which could significantly contribute to their development and progression. AIM To evaluate the influence of the gut microbiome on the pathogenesis and progression of various ocular diseases. METHODS An extensive search of the scientific literature was undertaken by adhering to Preferred Reporting Items for Systematic Reviews & Meta-Analyses standards, using PubMed (MEDLINE), Scopus, EMBASE, and the Cochrane Library as sources to locate studies addressing the relationship between the gut microbiome and human health. To capture all relevant publications, search terms were systematically applied across these major databases, without limiting the search by language or publication date. Inclusion criteria covered randomized controlled trials, non-randomized controlled trial, prospective studies, cross-sectional studies, and case-control studies. Out of the 3077 articles, 36 full texts were included in the review. RESULTS Ocular health appears to be shaped by the gut microbial community through mechanisms such as immune regulation, preservation of the blood–retinal barrier, and the generation of protective metabolites. Disturbances in this microbial balance can provoke measurable alterations in host immunity, providing a plausible immunopathogenic pathway that connects intestinal dysbiosis with eye disease. Both laboratory models and early human data suggest that targeted interventions, including prebiotics, probiotics, synbiotics, and faecal microbiota transfer, hold therapeutic potential. CONCLUSION The gut–eye relationship reflects a multifaceted interaction in which the intestinal microbiome contributes to ocular health through complex biological pathways. Integrating microbiome assessments into diagnostic methods can revolutionize disease management through early detection and targeted interventions. Further, randomised controlled clinical trials are necessary for ocular diseases to prove causal relationships.